These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20718658)

  • 41. [Immunostimulating activity of vaccines in the treatment of recurrent urinary tract infections. I].
    Koukalova D; Krocova Z; Vitek P; Macela A; Hajek V
    Bratisl Lek Listy; 1999 Mar; 100(3):129-34. PubMed ID: 10458054
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of bacterial infections of the female urinary tract by immunization of the patients.
    Grischke EM; Rüttgers H
    Urol Int; 1987; 42(5):338-41. PubMed ID: 3324441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Late events in assembly determine the polymeric structure and biological activity of secretory IgM.
    Brewer JW; Corley RB
    Mol Immunol; 1997 Mar; 34(4):323-31. PubMed ID: 9244345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal immunization for bacterial respiratory infections.
    Cripps AW
    Hum Vaccin; 2008; 4(6):396-9. PubMed ID: 18838872
    [No Abstract]   [Full Text] [Related]  

  • 45. Maternal immunization for the prevention of bacterial infection in young infants.
    Mulholland K
    Vaccine; 1998; 16(14-15):1464-7. PubMed ID: 9711789
    [No Abstract]   [Full Text] [Related]  

  • 46. Vaginal vaccine for recurrent urinary-tract infections.
    Das P
    Lancet Infect Dis; 2002 Feb; 2(2):68. PubMed ID: 11901648
    [No Abstract]   [Full Text] [Related]  

  • 47. Experimental vaccine for recurrent UTIs.
    Stephenson J
    JAMA; 2002 Feb; 287(6):702-3. PubMed ID: 11851515
    [No Abstract]   [Full Text] [Related]  

  • 48. [Prevention and treatment of recurrent urinary tract infection with a yishenkang granule].
    Sun JS
    Zhong Xi Yi Jie He Za Zhi; 1989 Aug; 9(8):469-71, 452. PubMed ID: 2598348
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The IgM pentamer is an asymmetric pentagon with an open groove that binds the AIM protein.
    Hiramoto E; Tsutsumi A; Suzuki R; Matsuoka S; Arai S; Kikkawa M; Miyazaki T
    Sci Adv; 2018 Oct; 4(10):eaau1199. PubMed ID: 30324136
    [TBL] [Abstract][Full Text] [Related]  

  • 50. This month in Investigative Urology: modifiers of susceptibility to urinary tract infection.
    Schaeffer AJ
    J Urol; 1990 Jan; 143(1):138. PubMed ID: 2294246
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of recurrent hordeolum with Broncasma Berna.
    Nakatani M
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():692. PubMed ID: 10696340
    [No Abstract]   [Full Text] [Related]  

  • 52. Approaches to modelling the human immune response in transition of candidates from research to development.
    Williamson D
    J Immunol Res; 2014; 2014():395302. PubMed ID: 24949489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Re: First Experience in the UK of Treating Women with Recurrent Urinary Tract Infections with the Bacterial Vaccine Uromune
    Schaeffer EM
    J Urol; 2018 Dec; 200(6):1144-1145. PubMed ID: 30838901
    [No Abstract]   [Full Text] [Related]  

  • 54. Editorial: Perspective of bacterial vaccines -part II.
    Yang X
    Curr Pharm Biotechnol; 2013; 14(11):939. PubMed ID: 24484389
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunization Treatment.
    Dent Regist; 1923 May; 77(5):234-237. PubMed ID: 33703820
    [No Abstract]   [Full Text] [Related]  

  • 56. Putting J chain back on the map: how might its expression define plasma cell development?
    Castro CD; Flajnik MF
    J Immunol; 2014 Oct; 193(7):3248-55. PubMed ID: 25240020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antigenic specificity and expression of a natural idiotope on human pentameric and hexameric IgM polymers.
    Petrušić V; Zivković I; Stojanović M; Stojićević I; Marinković E; Inić-Kanada A; Dimitijević L
    Immunol Res; 2011 Oct; 51(1):97-107. PubMed ID: 21786026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary tract infections in women: etiology and treatment options.
    Minardi D; d'Anzeo G; Cantoro D; Conti A; Muzzonigro G
    Int J Gen Med; 2011; 4():333-43. PubMed ID: 21674026
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in composition of IgM polymers in patients suffering from recurrent urinary bacterial infections after bacterial immunization treatment.
    Petrušić V; Stojanović M; Zivković I; Inić-Kanada A; Dimitrijević L
    Immunol Invest; 2010; 39(8):781-95. PubMed ID: 20718658
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Changes in pools of autoantibodies and anti-bacterial antibodies in patients suffering from recurrent infections of the urinary tract and undergoing bacterial immunization treatment.
    Stojanović M; Inić-Kanada A; Popović Z; Zivković I; Dimitrijević L
    Immunol Lett; 2004 Jun; 94(1-2):123-33. PubMed ID: 15234544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.